|
The National Pharmaceutical Pricing Authority has fixed / revised the prices in respect of 308 formulation packs in accordance with the provisions of the Drugs (Prices Control) Order (DPCO), 1995 and as per the established criteria and guidelines. Of these, Ceiling Prices in respect of 238 formulation packs have been fixed under DPCO, 1995. The prices of 70 non-ceiling packs which includes 31 imported insulin formulations have also been fixed by the NPPA.
The above price fixation / revision cases also cover derivative formulation packs based on the bulk drugs Chloroquine Phosphate, Norfloxacin, Ranitidine, Naproxen, Erythromycin Base, Erythromycin Stereate, Erythromycin Ethyl Succinate, Vitamin E, Vitamin C, Combination of Vitamin E & C, Detropropoxyphene Hydrochloride and Cefadroxyl Monohydrate for which prices have been fixed / revised downwards on suo-motu basis, considering reduced notified prices of the bulk drugs. It also includes 81 cases of Betamethasone Dipropionate and certain others formulations, formulated namely by M/s. Cipla, Sun Pharma, Wockhardt, Alkem and USV fixed after receipt of complaints and on the bases of available information.
Apart from the cases of price fixation / revision, NPPA has also fixed packing material cost norms in respect of metered dose inhalers under para 7 of DPCO, 1995.
The prices fixed / revised would become effective within 15 days from the date of notification in the official gazette or receipt of the Non-ceiling, price (NCP) Order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.
With this, the NPPA has fixed / revised the prices of 720 formulations in calendar year 2005 which is also a record.
SKM:PM
|
